Integrated Filing — IndAS


General information about company

Scrip Code 544138
NSE Symbol JGCHEM
MSEI Symbol NOTLISTED
ISIN INE0MB501011
Name of company J.G.CHEMICALS LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 17-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 13-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment ZINC OXIDE
Start date and time of board meeting 17-May-2025   14:00:00
End date and time of board meeting 17-May-2025   15:00:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2023-11-20
Indicate Company website link for updated RPT policy of the Company WWW.JGCHEM.COM
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
NOT APPLICABLE



Financial Results Ind-AS

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 755040000 2718200000
Other income 58190000 148210000
Total income 813230000 2866410000
2 Expenses
(a) Cost of materials consumed 596960000 2161040000
(b) Purchases of stock-in-trade 7030000 7030000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 24190000 39360000
(d) Employee benefit expense 20160000 85400000
(e) Finance costs 460000 2550000
(f) Depreciation, depletion and amortisation expense 3460000 13850000
(f) Other Expenses
1 Other Expenses 75600000 287180000
Total other expenses 75600000 287180000
Total expenses 727860000 2596410000
3 Total profit before exceptional items and tax 85370000 270000000
4 Exceptional items 0 0
5 Total profit before tax 85370000 270000000
6 Tax expense
7 Current tax 19500000 62170000
8 Deferred tax 2270000 7640000
9 Total tax expenses 21770000 69810000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0 0
11 Net Profit Loss for the period from continuing operations 63600000 200190000
12 Profit (loss) from discontinued operations before tax 0 0
13 Tax expense of discontinued operations 0 0
14 Net profit (loss) from discontinued operation after tax 0 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0 0
16 Total profit (loss) for period 63600000 200190000
17 Other comprehensive income net of taxes -38850000 22670000
18 Total Comprehensive Income for the period 24750000 222860000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 39186063000000 39186063000000
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 0
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.62 5.11
Diluted earnings (loss) per share from continuing operations 1.62 5.11
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.62 5.11
Diluted earnings (loss) per share from continuing and discontinued operations 1.62 5.11
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 74440000
Capital work-in-progress 4140000
Investment property 0
Goodwill 0
Other intangible assets 130000
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 132770000
Trade receivables, non-current 0
Loans, non-current 560000000
Other non-current financial assets 1930000
Total non-current financial assets 694700000
Deferred tax assets (net)
Other non-current assets 4700000
Total non-current assets 778110000
2 Current assets
Inventories 388940000
Current financial asset
Current investments 312890000
Trade receivables, current 490560000
Cash and cash equivalents 235950000
Bank balance other than cash and cash equivalents 739440000
Loans, current 0
Other current financial assets 120480000
Total current financial assets 1899320000
Current tax assets (net) 5090000
Other current assets 146690000
Total current assets 2440040000
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 3218150000
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 391860000
Other equity 2727650000
Total equity attributable to owners of parent 3119510000
Non controlling interest
Total equity 3119510000
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
Total non-current financial liabilities 0
Provisions, non-current 0
Deferred tax liabilities (net) 1170000
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities 1170000
Current liabilities
Current financial liabilities
Borrowings, current 0
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 4050000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 33930000
Total Trade payable 37980000
Other current financial liabilities 46680000
Total current financial liabilities 84660000
Other current liabilities 3120000
Provisions, current 9690000
Current tax liabilities (Net) 0
Deferred government grants, Current 0
Total current liabilities 97470000
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 98640000
Total equity and liabilites 3218150000
Disclosure of notes on assets and liabilities



Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Jan-2025 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether accounts are audited or unaudited Audited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Jan-2025 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement of the defined benefit plans 400000 400000
2 Equity Instruments through other Comprehensive Income -45680000 26100000
Total Amount of items that will not be reclassified to profit and loss -45280000 26500000
2 Income tax relating to items that will not be reclassified to profit or loss -6430000 3830000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0 0
5 Total Other comprehensive income -38850000 22670000



Cash flow statement, indirect

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 2024-04-01
B Date of end of reporting period 2025-03-31
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 270000000
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2550000
Adjustments for decrease (increase) in inventories -162020000
Adjustments for decrease (increase) in trade receivables, current -47570000
Adjustments for decrease (increase) in trade receivables, non-current 0
Adjustments for decrease (increase) in other current assets 0
Adjustments for decrease (increase) in other non-current assets 0
Adjustments for other financial assets, non-current 0
Adjustments for other financial assets, current -20070000
Adjustments for other bank balances 0
Adjustments for increase (decrease) in trade payables, current 15090000
Adjustments for increase (decrease) in trade payables, non-current 0
Adjustments for increase (decrease) in other current liabilities 0
Adjustments for increase (decrease) in other non-current liabilities 0
Adjustments for depreciation and amortisation expense 13850000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for provisions, current 3010000
Adjustments for provisions, non-current 0
Adjustments for other financial liabilities, current 0
Adjustments for other financial liabilities, non-current 0
Adjustments for unrealised foreign exchange losses gains -2080000
Adjustments for dividend income 60000
Adjustments for interest income 118780000
Adjustments for share-based payments 0
Adjustments for fair value losses (gains) 0
Adjustments for undistributed profits of associates 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) -690000
Other adjustments for non-cash items -20140000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments for reconcile profit (loss) -336910000
Net cash flows from (used in) operations -66910000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 67300000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities -134210000
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property, plant and equipment 970000
Purchase of property, plant and equipment 8900000
Proceeds from sales of investment property 511360000
Purchase of investment property 464780000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Proceeds from sales of intangible assets under development 0
Purchase of intangible assets under development 0
Proceeds from sales of goodwill 0
Purchase of goodwill 0
Proceeds from biological assets other than bearer plants 0
Purchase of biological assets other than bearer plants 0
Proceeds from government grants 0
Proceeds from sales of other long-term assets 0
Purchase of other long-term assets 0
Cash advances and loans made to other parties 310000000
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 60000
Interest received 87340000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 265120000
Net cash flows from (used in) investing activities 81170000
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0
Payments from changes in ownership interests in subsidiaries 0
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Payments to acquire or redeem entity's shares 0
Payments of other equity instruments 0
Proceeds from exercise of stock options 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings -1590000
Repayments of borrowings 0
Payments of lease liabilities 0
Dividends paid 0
Interest paid 2500000
Income taxes paid (refund) 0
Other inflows (outflows) of cash -143840000
Net cash flows from (used in) financing activities -147930000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -200970000
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -200970000
Cash and cash equivalents cash flow statement at beginning of period 436930000
Cash and cash equivalents cash flow statement at end of period 235960000







Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Statement on impact of audit qualification
Auditor's opinion Qualified opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 S JAYKISHAN Yes 30-Apr-2028


Financial details

Sr. Particulars Audited Figures (as reported before adjusting for qualifications) Adjusted Figures (audited figures after adjusting for qualifications)
1 Turnover / Total income 2866410000 2866410000
2 Total Expenditure 2596410000 2596410000
3 Net Profit/(Loss) 270000000 270000000
4 Earnings Per Share 5.11 5.11
5 Total Assets 3218150000 3218150000
6 Total Liabilities 98640000 98640000
7 Net Worth 3119510000 3119510000




Signatories detail

Name of CEO / Managing director ANIRUDH JHUNJHUNWALA
Name of CFO ANUJ JHUNJHUNWALA
Name of audit committee chairman SUKANTA NAG
Name of statutory auditor S JAYKISHAN
Name of other signatory, if any, with designation
Place KOLKATA
Date 17-May-2025



Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Purchase of goods or services 150000000 NIL 20860000 0 0
2 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Sale of goods or services 70000000 NIL 8810000 0 0
3 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Any other transaction Management Consultancy Services 30000000 NIL 12380000 0 0
4 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Any other transaction Corporate Guarantee & Commission 50000000 NIL 20000000 0 0
5 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Loan 500000000 NIL 230000000 330000000 560000000 Loan 0.0918 Long Term Unsecured Working Capital Requirement
6 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Interest received 47050000 NIL 20720000 0 0
7 J G Chemicals Limited Vision Projects & Finvest Pvt Ltd Member of the Promoter Group Company Any other transaction Rent Paid 220000 NIL 90000 0 0
8 J G Chemicals Limited BDJ Impex Private Limited Member of the Promoter Group Company Any other transaction Equipment Hire Charges 1200000 NIL 570000 0 0
9 J G Chemicals Limited BDJ Impex Private Limited Member of the Promoter Group Company Any other transaction Rent Paid 4400000 NIL 2080000 0 0
10 J G Chemicals Limited BDJ Impex Private Limited Member of the Promoter Group Company Any other transaction Rent Received 90000 NIL 40000 0 0
11 J G Chemicals Limited BDJ Impex Private Limited Member of the Promoter Group Company Any other transaction Repair and Maintainance 1500000 NIL 360000 0 0
12 J G Chemicals Limited Vision Projects & Finvest Pvt Ltd Member of the Promoter Group Company Any other transaction Repair and Maintainance 1000000 NIL 0 0 0
13 J G Chemicals Limited Anirudh Jhunjhunwala Promoter of the Listed Company Remuneration 16500000 NIL 8080000 0 0
14 J G Chemicals Limited Anuj Jhunjhunwala Promoter of the Listed Company Remuneration 15000000 NIL 7960000 0 0
15 J G Chemicals Limited Suresh Jhunjhunwala Promoter of the Listed Company Remuneration 17000000 NIL 8300000 0 0
16 J G Chemicals Limited BDJ Foundation Member of the Promoter Group Company Any other transaction CSR EXPENSE 4600000 NIL 100000 0 0
17 J G Chemicals Limited Anirudh Jhunjhunwala HUF Member of the Promoter Group Company Any other transaction Excess Aount Received from Selling Share Holders 0 NIL 470000 0 0
18 J G Chemicals Limited Suresh Kumar Jhunjhunwala HUF Member of the Promoter Group Company Any other transaction Excess Aount Received from Selling Share Holders 0 NIL 970000 0 0
19 J G Chemicals Limited Jayanti Commercial Private Limited Member of the Promoter Group Company Any other transaction Excess Aount Received from Selling Share Holders 0 NIL 0 0 0
20 J G Chemicals Limited Vision Projects & Finvest Pvt Ltd Member of the Promoter Group Company Any other transaction Excess Aount Received from Selling Share Holders 0 NIL 1560000 0 0
21 J G Chemicals Limited Swati Poddar Key Managerial Person Remuneration 0 NIL 720000 0 0
22 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Any other transaction Re-imbursement of Expenses 1000000 NIL 550000 0 0
23 J G Chemicals Limited Vision Projects & Finvest Pvt Ltd Member of the Promoter Group Company Investment 0 NIL 45670000 150080000 104400000 Textual Information(1)
24 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Investment 0 NIL 0 10930000 10930000
25 J G Chemicals Limited BDJ Oxides Private Limited Material Subsidiary Any other transaction Others Payable 0 NIL 27000000 0 27000000
26 J G Chemicals Limited BDJ Impex Private Limited Member of the Promoter Group Company Any other transaction Security Deposit Paid 0 NIL 0 950000 950000
27 J G Chemicals Limited BDJ Impex Private Limited Member of the Promoter Group Company Any other transaction Security Deposit Received 0 NIL 0 20000 20000
Total value of transaction during the reporting period 417290000



Text Block

Textual Information(1) The decrease in value during the reporting period is due to fair valuation of shares routed through Other Comprehensive Income


Format for Disclosing Outstanding Default on Loans and Debt Securities

Sr. No. Particulars Amount Remarks
1. Loans / revolving facilities like cash credit from banks / financial institutions
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
2. Unlisted debt securities i.e. NCDs and NCRPS
A Total amount outstanding as on date
B Of the total amount outstanding, amount of default as on date
3. Total financial indebtedness of the listed entity including short-term and long-term debt